Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.

NCT00805350 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00805350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2008
Completion date
June 30, 2009
Enrollment
637 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

primary insomnia